相关实验视频
Updated: May 3, 2026

07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
7.9K
HLA-C*05:292N,一种通过下一代测序识别的新型HLA-C无基因
Justine Schmitt1, André Gothot1
1HLA Typing Laboratory, Liège University Hospital, Liège, Belgium.
HLA
|February 11, 2024
概括
发现了一种新的人类白细胞抗原-C (HLA-C) 变体,HLA-C*05:292N. 它通过特定的删除与已知的等位基因不同,表明HLA-C.中的新遗传变异.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类白细胞抗原 (HLA) 系统
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应和移植中起着至关重要的作用.
- HLA基因中的遗传变异,特别是HLA-C,有助于形成多样化的免疫特征.
- 准确的HLA类型定型对于在移植中匹配捐赠者和接受者以及了解疾病关联至关重要.
研究的目的:
- 为了表征一种新发现的HLA-C等位基因,HLA-C*05:292N.
- 详细介绍HLA-C*05:292N和之前描述的HLA-C等位基因之间的特定遗传差异.
- 为全面对HLA遗传多样性的编目做出贡献.
主要方法:
- 使用了高分辨率的HLA排版技术.
- 用DNA测序来识别和分析变异.
- 进行了与参考HLA数据库对新型等位基因序列的比较.
主要成果:
- 一个新的HLA-C等位基因被发现,被指定为HLA-C*05:292N.
- 该等位基因因与HLA-C*05:01:01:08通过一个框架转移突变区分开来.
- 这种突变涉及基因组DNA位置758.8的删除.
结论:
- 鉴定HLA-C*05:292N扩大了已知的HLA-C位点的等位基多样性.
- 这一发现强调了持续HLA类型化工作的重要性,以捕获罕见和新型变异.
- 了解这些变异对于在临床和研究环境中进行精确的免疫遗传评估至关重要.
相关概念视频
Next-generation Sequencing
87.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.9K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K

